A Phase I Study Comparing Pharmacokinetics and Safety of Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer (FERMATA)
- Status
- UNKNOWN
- Phase
- PHASE3
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)
- Status
- UNKNOWN
- Phase
- PHASE2
Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Pan Tumor Rollover Study
- Status
- RECRUITING
- Phase
- PHASE2
Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis
- Status
- COMPLETED
- Phase
- N/A
Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
- Status
- TERMINATED
- Phase
- PHASE1
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE3
Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE3
Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification
- Status
- COMPLETED
- Phase
- PHASE4
Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a KRAS Mutation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2